vs

Side-by-side financial comparison of Trump Media & Technology Group Corp. (DJT) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $1.0M, roughly 1.7× Trump Media & Technology Group Corp.). INVO Fertility, Inc. runs the higher net margin — -150.5% vs -60263.0%, a 60112.4% gap on every dollar of revenue. On growth, INVO Fertility, Inc. posted the faster year-over-year revenue change (22.6% vs 0.5%). Trump Media & Technology Group Corp. produced more free cash flow last quarter ($12.1M vs $-1.8M). Over the past eight quarters, Trump Media & Technology Group Corp.'s revenue compounded faster (14.2% CAGR vs 12.8%).

Trump Media & Technology Group Corp. (TMTG) is an American media and technology company headquartered in Sarasota, Florida. It runs the Truth Social social-media platform and is majority-owned by the Donald J. Trump Revocable Trust.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

DJT vs IVF — Head-to-Head

Bigger by revenue
IVF
IVF
1.7× larger
IVF
$1.8M
$1.0M
DJT
Growing faster (revenue YoY)
IVF
IVF
+22.1% gap
IVF
22.6%
0.5%
DJT
Higher net margin
IVF
IVF
60112.4% more per $
IVF
-150.5%
-60263.0%
DJT
More free cash flow
DJT
DJT
$13.9M more FCF
DJT
$12.1M
$-1.8M
IVF
Faster 2-yr revenue CAGR
DJT
DJT
Annualised
DJT
14.2%
12.8%
IVF

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
DJT
DJT
IVF
IVF
Revenue
$1.0M
$1.8M
Net Profit
$-605.8M
$-2.6M
Gross Margin
45.4%
Operating Margin
-43010.6%
-93.1%
Net Margin
-60263.0%
-150.5%
Revenue YoY
0.5%
22.6%
Net Profit YoY
-1509.0%
-62.2%
EPS (diluted)
$-2.38
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DJT
DJT
IVF
IVF
Q4 25
$1.0M
Q3 25
$972.9K
$1.8M
Q2 25
$883.3K
$1.9M
Q1 25
$821.2K
$1.6M
Q4 24
$1.0M
$1.7M
Q3 24
$1.0M
$1.4M
Q2 24
$836.9K
$1.8M
Q1 24
$770.5K
$1.6M
Net Profit
DJT
DJT
IVF
IVF
Q4 25
$-605.8M
Q3 25
$-54.8M
$-2.6M
Q2 25
$-20.0M
$-5.3M
Q1 25
$-31.7M
$-17.4M
Q4 24
$-37.6M
$-3.6M
Q3 24
$-19.2M
$-1.6M
Q2 24
$-16.4M
$-2.2M
Q1 24
$-327.6M
$-1.6M
Gross Margin
DJT
DJT
IVF
IVF
Q4 25
45.4%
Q3 25
54.1%
Q2 25
61.2%
Q1 25
59.0%
35.2%
Q4 24
63.4%
41.4%
Q3 24
87.8%
31.0%
Q2 24
95.7%
53.1%
Q1 24
87.9%
45.3%
Operating Margin
DJT
DJT
IVF
IVF
Q4 25
-43010.6%
Q3 25
-5926.4%
-93.1%
Q2 25
-4925.6%
-160.4%
Q1 25
-4814.3%
-1042.1%
Q4 24
-4535.0%
-202.0%
Q3 24
-2340.0%
-90.7%
Q2 24
-2229.5%
-100.9%
Q1 24
-12764.8%
-95.7%
Net Margin
DJT
DJT
IVF
IVF
Q4 25
-60263.0%
Q3 25
-5637.6%
-150.5%
Q2 25
-2264.5%
-283.6%
Q1 25
-3863.4%
-1060.1%
Q4 24
-3763.0%
-211.3%
Q3 24
-1904.1%
-113.8%
Q2 24
-1955.8%
-122.2%
Q1 24
-42517.8%
-101.3%
EPS (diluted)
DJT
DJT
IVF
IVF
Q4 25
$-2.38
Q3 25
$-0.20
$-0.77
Q2 25
$-0.08
$-13.30
Q1 25
$-0.14
$-12.53
Q4 24
$1.45
$14.86
Q3 24
$-0.10
$-15.11
Q2 24
$-0.10
$-22.39
Q1 24
$-3.61
$-7.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DJT
DJT
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$439.6M
Total DebtLower is stronger
$947.1M
$2.0M
Stockholders' EquityBook value
$1.6B
$5.8M
Total Assets
$2.6B
$18.8M
Debt / EquityLower = less leverage
0.58×
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DJT
DJT
IVF
IVF
Q4 25
$439.6M
Q3 25
$716.5M
Q2 25
$2.0B
Q1 25
$759.0M
Q4 24
$776.8M
Q3 24
$672.9M
Q2 24
$344.0M
Q1 24
$233.7M
Total Debt
DJT
DJT
IVF
IVF
Q4 25
$947.1M
Q3 25
$950.8M
$2.0M
Q2 25
$944.3M
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DJT
DJT
IVF
IVF
Q4 25
$1.6B
Q3 25
$2.3B
$5.8M
Q2 25
$2.3B
$2.6M
Q1 25
$891.7M
$3.3M
Q4 24
$913.6M
$12.7M
Q3 24
$816.5M
$-23.3K
Q2 24
$341.7M
$1.4M
Q1 24
$210.3M
$10.2K
Total Assets
DJT
DJT
IVF
IVF
Q4 25
$2.6B
Q3 25
$3.3B
$18.8M
Q2 25
$3.2B
$19.3M
Q1 25
$918.9M
$31.7M
Q4 24
$938.3M
$46.4M
Q3 24
$837.8M
$17.0M
Q2 24
$356.5M
$17.8M
Q1 24
$274.4M
$17.3M
Debt / Equity
DJT
DJT
IVF
IVF
Q4 25
0.58×
Q3 25
0.42×
0.34×
Q2 25
0.41×
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DJT
DJT
IVF
IVF
Operating Cash FlowLast quarter
$12.1M
$-1.8M
Free Cash FlowOCF − Capex
$12.1M
$-1.8M
FCF MarginFCF / Revenue
1205.3%
-101.6%
Capex IntensityCapex / Revenue
0.4%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$14.2M
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DJT
DJT
IVF
IVF
Q4 25
$12.1M
Q3 25
$10.1M
$-1.8M
Q2 25
$2.3M
$-1.7M
Q1 25
$-9.7M
$-3.5M
Q4 24
$-8.3M
$-617.4K
Q3 24
$-21.9M
$-640.8K
Q2 24
$-21.4M
$-1.5M
Q1 24
$-9.3M
$-260.6K
Free Cash Flow
DJT
DJT
IVF
IVF
Q4 25
$12.1M
Q3 25
$10.1M
$-1.8M
Q2 25
$1.8M
$-1.7M
Q1 25
$-9.7M
$-3.6M
Q4 24
$-8.3M
$-696.3K
Q3 24
$-24.8M
Q2 24
$-23.6M
$-1.5M
Q1 24
$-310.3K
FCF Margin
DJT
DJT
IVF
IVF
Q4 25
1205.3%
Q3 25
1034.0%
-101.6%
Q2 25
198.2%
-92.6%
Q1 25
-1186.2%
-216.9%
Q4 24
-834.1%
-40.6%
Q3 24
-2450.8%
Q2 24
-2817.6%
-82.3%
Q1 24
-19.7%
Capex Intensity
DJT
DJT
IVF
IVF
Q4 25
0.4%
Q3 25
1.4%
0.5%
Q2 25
62.5%
0.5%
Q1 25
0.4%
0.9%
Q4 24
0.3%
4.6%
Q3 24
285.8%
0.0%
Q2 24
255.9%
3.0%
Q1 24
0.0%
3.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons